SPOTLIGHT -
Ms Kuntz is the assistant managing editor of Psychiatric Times.
Do Amyloid Plaques Cause Alzheimer Disease?
A new study finds amyloid plaques accelerate the breakup of neurotransmitters, worsening neurodegenerative diseases like Alzheimer disease.
When Music Makes a Difference: Documentary Wins Award
The documentary Orchestrating Change has won the 2021 Austen Riggs Erikson Prize for Excellence in Mental Health Media.
Moving Forward: Alzheimer Treatment Granted Breakthrough Therapy Designation
More potential good news for treating Alzheimer disease, as an 18-month open-label extension for lecanemab allows for its breakthrough status.
Positive End-Of-Phase 2 Meeting for Extended-Release Risperidone Capsule
An extended release, ultra-long acting antipsychotic takes another step forward in the approval process.
Fighting the Opioid Epidemic: The APA’s Call to Action
After the largest increase in overdose deaths in 50 years, the American Psychiatric Association sends out the call for improved substance use care.
New Treatment for Acute Suicidal Ideation and Behavior
If approved, SLS-002 would be only the second approved product for ASIB.
Do Blood Clotting and Immune System Contribute to Psychosis?
New research may help better understand psychosis etiology as well as provide potential biomarkers for psychosis.
First Participant Joins Opioid Use Disorder Treatment Study
Novel digital therapy modia will be evaluated in combination with sublingual buprenorphine/naloxone background therapy to see whether it is superior in reducing opioid use.
Rhode Island: The First State to Allow Harm Reduction Centers for Safe Drug Consumption
To combat drug overdoses, the Rhode Island governor signed a bill allowing people to consume pre-obtained drugs under safe, professional supervision of trained staff.
Narrower Label for Alzheimer Disease Treatment, Aducanumab
Following criticism for its wide-labeled June approval, the FDA has decided to narrow the patient recommendation for aducanumab.
Another New Alzheimer Drug on the Horizon
Donanemab for the treatment of Alzheimer disease has received Breakthrough Therapy designation from the FDA.
Scotland Introduces Bill in Favor of Assisted Dying
For the first time since 2015, Scottish Parliament is considering legislation on medical aid in dying.
Challenging Diagnoses, New Treatments, and Clinical Conundrums Discussed at Annual Meeting
The 2021 American Psychiatric Association Virtual Annual Meeting brought together leaders in psychiatry to discuss hot topics including diversity, COVID-19, mood disorders, and more.
Vaccines Do Not Affect Male Fertility
According to a recent study, COVID-19 vaccines did not impact sperm parameters.
Patent Brings Psychiatry One Step Closer to Precision Medicine
Adial’s AD04 for the treatment of alcohol use disorder received a Notice of Allowance from the US Patent and Trademark Office.
Are Migraines and PTSD Linked?
Genes may hold the answer to the puzzling comorbidity of migraines and posttraumatic stress disorder.
Prime Day Deals for Mental Health
These deals can help boost you and your patients’ mental health.
First in Class Therapeutic for MDD Shows Promising Results
Zuranolone showed statistically significant improvement in depressive symptoms in this latest study.
Poetry for PTSD and Preventing Suicide
This renowned psychiatrist is donating a portion of the proceeds from his book sales to help stop US military veteran suicides.
A Bill to End the War on Drugs
The Drug Policy Reform Act, introduced today, intends to decriminalize drug use and possession, providing health-centered approaches and rehabilitation instead.
Children’s Mental Health Response to COVID-19
What impact has the pandemic had on children's mental health?
Vaccinated Physicians
Have you gotten your COVID-19 vaccine?
Liftoff! Brain Monitoring Startup Bound for Space
This is a rare opportunity for researchers and entrepreneurs from a variety of fields to conduct experiments in space.
PTSD by the Numbers
June is posttraumatic stress disorder (PTSD) Awareness Month!
First New Treatment Approved for Alzheimer Disease in Nearly 2 Decades
This one-of-a-kind Alzheimer disease treatment targets the amyloid beta plaques in the brain, potentially slowing cognitive decline.
FDA Approves a New Atypical Antipsychotic With Less Adverse Effects
This combination treatment of olanzapine and samidorphan caused significantly less weight gain in patients with schizophrenia and bipolar I disorder.
What Is an SGM Community?
What terms are used to describe SGM and LGBTQ+ identities?
Going Maskless
Over a third of older Americans aren't comfortable taking off their masks until 2022.
Drug for the Treatment of Agitation Moves Closer to Reality
This treatment for agitation associated with schizophrenia and bipolar disorder is moving up the FDA ladder…
Posters Indicate Potential Benefit for Patients With Schizophrenia
Two posters presented at the APA virtual meeting demonstrated long-acting injectable positive results, costs savings, and increased telehealth for patients with schizophrenia.